ClearPoint Neuro Inc. - Common Stock (NQ:CLPT)

10.28 -0.41 (-3.84%)

Delayed Quote Updated: 11:04 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ClearPoint Neuro Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

90 Biggest Movers From Yesterday ↗

May 13, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...

Via Benzinga

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Earnings Scheduled For August 10, 2021 ↗

August 10, 2021

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

58 Stocks Moving In Thursday's Mid-Day Session ↗

May 12, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 11, 2022

Gainers

Via Benzinga

Recap: ClearPoint Neuro Q1 Earnings ↗

May 11, 2022

ClearPoint Neuro (NASDAQ:CLPT) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings ClearPoint Neuro beat...

Via Benzinga

ClearPoint Neuro: Q4 Earnings Insights ↗

March 01, 2022

ClearPoint Neuro (NASDAQ:CLPT) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

56 Biggest Movers From Yesterday ↗

February 17, 2022

Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead...

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

February 16, 2022

Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral...

Via Benzinga

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa ↗

February 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following...

Via Benzinga

23 Stocks Moving in Wednesday's Pre-Market Session ↗

February 16, 2022

Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) rose 41.8% to $1.90 in pre-market trading after the company announced it entered into an amended and restated collaboration...

Via Benzinga

ClearPoint Neuro, Inc. (CLPT) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

CLPT earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 04, 2021

Gainers Longeveron (NASDAQ:LGVN) shares ...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 16, 2021

Gainers Stealth BioTherapeutics (NASDAQ:

Via Benzinga

66 Biggest Movers From Yesterday ↗

August 12, 2021

Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic...

Via Benzinga

Topics Initial Public Offering

ClearPoint Neuro Stock Dives After Q2 Earnings ↗

August 11, 2021

ClearPoint Neuro Inc (NASDAQ: CLPT) reported Q2 revenue of $3.4 million, a 38% Y/Y increase, below the consensus estimate of $3.68 million. Functional neurosurgery...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 11, 2021

Gainers Dyadic International (NASDAQ:DYAI) stock increased by 28.96% to $4.63 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

ClearPoint Neuro, Inc. (CLPT) Q2 2021 Earnings Call Transcript ↗

August 11, 2021

CLPT earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 10, 2021

Gainers CohBar (NASDAQ:CWBR) shares incr...

Via Benzinga

Recap: ClearPoint Neuro Q2 Earnings ↗

August 10, 2021

Shares of ClearPoint Neuro (NASDAQ:CLPT) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 54.55% year over...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 22, 2021

Gainers Tenax Therapeutics (NASDAQ:TENX) ...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

ClearPoint Neuro: Return On Capital Employed Insights ↗

June 18, 2021

ClearPoint Neuro (NASDAQ:CLPT) reported Q1 sales of $4.03 million. Earnings fell to a loss of $2.18 million, resulting in a 3.72% decrease from last quarter. In Q4, ClearPoint...

Via Benzinga

ClearPoint Neuro Insights: Return On Capital Employed ↗

June 03, 2021

During Q1, ClearPoint Neuro (NASDAQ:CLPT) brought in sales totaling $4.03 million. However, earnings decreased 3.72%, resulting in a loss of $2.18 million. ClearPoint Neuro...

Via Benzinga

MedTech Round Up: Update On Lucira Health, Second Sight Medical ClearPoint Neuro, Medtronic, Sientra ↗

May 12, 2021

Lucira Health Inc (NASDAQ: LHDX) has announced that its Lucira Check IT COVID-19 test kit is now available on Amazon.com in the US. Each Lucira Check IT test...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 12, 2021

Gainers Second Sight Medical (NASDAQ:EYES) shares increased by 25.39% to $6.27 during Wednesday's pre-market session. The company's market cap stands at $174.9...

Via Benzinga

ClearPoint Neuro, Inc. (CLPT) Q1 2021 Earnings Call Transcript ↗

May 12, 2021

CLPT earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

ClearPoint Neuro: Q1 Earnings Insights ↗

May 11, 2021

Shares of ClearPoint Neuro (NASDAQ:CLPT) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 0.00% over...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.